We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novavax Expands Vaccine Manufacturing Capacity to 2 Billion Doses
Novavax Expands Vaccine Manufacturing Capacity to 2 Billion Doses
Novavax has expanded its COVID-19 vaccine manufacturing agreement with the Serum Institute of India to produce more than 2 billion doses of the vaccine annually.